Sansure Biotech Past Earnings Performance
Past criteria checks 1/6
Sansure Biotech's earnings have been declining at an average annual rate of -9%, while the Medical Equipment industry saw earnings growing at 7.7% annually. Revenues have been declining at an average rate of 25.2% per year. Sansure Biotech's return on equity is 4.8%, and it has net margins of 32%.
Key information
-9.0%
Earnings growth rate
-9.4%
EPS growth rate
| Medical Equipment Industry Growth | 16.0% |
| Revenue growth rate | -25.2% |
| Return on equity | 4.8% |
| Net Margin | 32.0% |
| Last Earnings Update | 31 Mar 2024 |
Recent past performance updates
Revenue & Expenses BreakdownBeta
How Sansure Biotech makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Mar 24 | 1,203 | 385 | 638 | 205 |
| 31 Dec 23 | 1,007 | 364 | 552 | 195 |
| 30 Sep 23 | 3,015 | 638 | 868 | 289 |
| 30 Jun 23 | 4,188 | 904 | 930 | 321 |
| 31 Mar 23 | 5,206 | 1,345 | 949 | 334 |
| 31 Dec 22 | 6,450 | 1,937 | 985 | 331 |
| 30 Sep 22 | 5,316 | 2,084 | 599 | 276 |
| 30 Jun 22 | 5,176 | 2,247 | 568 | 235 |
| 31 Mar 22 | 4,791 | 2,272 | 499 | 208 |
| 31 Dec 21 | 4,515 | 2,243 | 507 | 187 |
| 30 Sep 21 | 4,425 | 2,361 | 464 | 111 |
| 30 Jun 21 | 4,691 | 2,506 | 566 | 106 |
| 31 Mar 21 | 5,526 | 3,046 | 672 | 95 |
| 31 Dec 20 | 4,763 | 2,617 | 627 | 83 |
| 30 Sep 20 | 3,727 | 2,034 | 575 | 76 |
| 30 Jun 20 | 2,299 | 1,263 | 355 | 50 |
| 31 Mar 20 | 683 | 233 | 211 | 40 |
| 31 Dec 19 | 365 | 39 | 161 | 39 |
| 31 Dec 18 | 303 | 7 | 134 | 35 |
| 31 Dec 17 | 225 | -11 | 105 | 28 |
Quality Earnings: 688289 has a high level of non-cash earnings.
Growing Profit Margin: 688289's current net profit margins (32%) are higher than last year (25.8%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 688289's earnings have declined by 9% per year over the past 5 years.
Accelerating Growth: 688289's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: 688289 had negative earnings growth (-71.4%) over the past year, making it difficult to compare to the Medical Equipment industry average (-0.5%).
Return on Equity
High ROE: 688289's Return on Equity (4.8%) is considered low.